5 big analyst AI moves: Apple lifted to Buy, AI chip bets reassessed
Johnson Controls International PLC stock reached an all-time high of 112.79 USD, marking a significant milestone for the $73.35 billion market cap company. According to InvestingPro data, the company has maintained dividend payments for 55 consecutive years, with an impressive 8.11% dividend growth in the last twelve months. This achievement reflects a robust performance over the past year, during which the stock has seen a remarkable 47.08% increase, with a 36.42% gain in just the last six months. The surge in stock price highlights the company’s strong market position and investor confidence, supported by analyst targets reaching as high as $133 per share. As Johnson Controls continues to innovate and expand its operations, this all-time high underscores its growth trajectory and potential for future gains. Based on current metrics, InvestingPro’s Fair Value analysis suggests the stock may be slightly overvalued. For deeper insights and access to 13 additional ProTips about Johnson Controls, including detailed financial health metrics and growth indicators, explore the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Johnson Controls International plc has announced an 8% increase in its quarterly dividend, raising it to $0.40 per share. This decision by the board of directors reflects a $0.03 increase from the previous quarter, with the dividend payable on October 17, 2025. Additionally, Johnson Control Navy Systems LLC, a subsidiary, has secured two significant contracts with the U.S. Navy. The first contract, valued at $112.4 million, is for high-efficiency air conditioning chiller plants and related materials, with a potential increase to $202.3 million if an option is exercised. A second contract, worth approximately $156 million, covers similar equipment and auxiliary components for the Navy. In leadership news, Todd Grabowski has been appointed as the new Vice President and President of the Americas segment, effective October 1, 2025, succeeding Nate Manning. Manning will remain in an advisory role until the end of the year to ensure a smooth transition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.